EUVIMEDEUVIMED entdecken
Crossref

Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization

Luyao Shen, Cong Wang, Ran Ren, Xudong Liu, Dongqin Zhou, Yu Chen, Yu Zhou, Juan Lei, Yang Xiao, Nan Zhang, Huakan Zhao, Yongsheng Li

Inflammation Research · 2024-09 · 73 (9) · 1493-1510

DOI: 10.1007/s00011-024-01910-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation Research, online erschienen am 10.07.2024. Verfasst von Luyao Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital & Yuying Children's Hospital, The Second School of Medicine, Wenzhou Medical University, Wenzhou, 325030, Zhejiang, Ch…. Hauptthemen laut MEDLINE: Colitis, Dextran Sulfate, Fibroblast Growth Factors, Macrophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research and breeding project of Chongqing Medical Biotechnology Association, Performance Incentive for Scientific Research Institutions of Chongqing Guide Special Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE AND DESIGN: Compelling evidence indicates that dysregulated macrophages may play a key role in driving inflammation in inflammatory bowel disease (IBD). Fibroblast growth factor (FGF)-19, which is secreted by ileal enterocytes in response to bile acids, has been found to be significantly lower in IBD patients compared to healthy individuals, and is negatively correlated with the severity of diarrhea. This study aims to explore the potential impact of FGF19 signaling on macrophage polarization and its involvement in the pathogenesis of IBD. METHODS: The dextran sulfate sodium (DSS)-induced mouse colitis model was utilized to replicate the pathology of human IBD. Mice were created with a conditional knockout of FGFR4 (a specific receptor of FGF19) in myeloid cells, as well as mice that overexpressing FGF19 specifically in the liver. The severity of colitis was measured using the disease activity index (DAI) and histopathological staining. Various techniques such as Western Blotting, quantitative PCR, flow cytometry, and ELISA were employed to assess polarization and the expression of inflammatory genes. RESULTS: Myeloid-specific FGFR4 deficiency exacerbated colitis in the DSS mouse model. Deletion or inhibition of FGFR4 in bone marrow-derived macrophages (BMDMs) skewed macrophages towards M1 polarization. Analysis of transcriptome sequencing data revealed that FGFR4 deletion in macrophages significantly increased the activity of the complement pathway, leading to an enhanced inflammatory response triggered by LPS. Mechanistically, FGFR4-knockout in macrophages promoted complement activation and inflammatory response by upregulating the nuclear factor-κB (NF-κB)-pentraxin3 (PTX3) pathway. Additionally, FGF19 suppressed these pathways and reduced inflammatory response by activating FGFR4 in inflammatory macrophages. Liver-specific overexpression of FGF19 also mitigated inflammatory responses induced by DSS in vivo. CONCLUSION: Our study highlights the significance of FGF19-FGFR4 signaling in macrophage polarization and the pathogenesis of IBD, offering a potential new therapeutic target for IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisDextran SulfateFibroblast Growth FactorsMacrophagesReceptor, Fibroblast Growth Factor, Type 4AnimalsMaleMiceColonDisease Models, AnimalLiverMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

FGF19FGFR4Inflammatory bowel diseaseMacrophage polarizationPTX3

Substanzen

Dextran SulfateFgfr4 protein, mousefibroblast growth factor 15, mouseFibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 4

Autor:innen und Institutionen

  • The Second Affiliated Hospital & Yuying Children's Hospital, The Second School of Medicine, Wenzhou Medical University, Wenzhou, 325030, Zhejiang, China.
  • School of Pharmacy, Wenzhou Medical University, Wenzhou, 325030, Zhejiang, China.
  • Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, 400044, China.
  • Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China. hk_zhao@cqu.edu.cn.
  • School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, 400044, China. hk_zhao@cqu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Research and breeding project of Chongqing Medical Biotechnology Association
  • Performance Incentive for Scientific Research Institutions of Chongqing Guide Special Projects
  • Major International (Regional) Joint Research Program of the National Natural Science Foundation of China
  • Chongqing Young and Middle-aged Medical Talents Project
  • Funding for Chongqing Young and Middle-Aged Medical Excellence Team

Zitieren

APA

Shen, L., Wang, C., Ren, R., Liu, X., Zhou, D., Chen, Y., Zhou, Y., Lei, J., Xiao, Y., Zhang, N., Zhao, H., & Li, Y. (2024). Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization. Inflammation Research, 73(9), 1493-1510. https://doi.org/10.1007/s00011-024-01910-8

Vancouver

Shen L, Wang C, Ren R, Liu X, Zhou D, Chen Y, et al. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization. Inflammation Research. 2024;73(9):1493-1510. doi:10.1007/s00011-024-01910-8

BibTeX
@article{Shen2024,
  author = {Shen, Luyao and Wang, Cong and Ren, Ran and Liu, Xudong and Zhou, Dongqin and Chen, Yu and Zhou, Yu and Lei, Juan and Xiao, Yang and Zhang, Nan and Zhao, Huakan and Li, Yongsheng},
  title = {Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization},
  journal = {Inflammation Research},
  year = {2024},
  volume = {73},
  number = {9},
  pages = {1493--1510},
  doi = {10.1007/s00011-024-01910-8}
}
Kostenlos starten →